150 related articles for article (PubMed ID: 17921818)
1. Identification of the vasodilatory endothelial cannabinoid receptor in the human pulmonary artery.
Kozłowska H; Baranowska M; Schlicker E; Kozłowski M; Laudański J; Malinowska B
J Hypertens; 2007 Nov; 25(11):2240-8. PubMed ID: 17921818
[TBL] [Abstract][Full Text] [Related]
2. Endothelium-dependent mechanisms of the vasodilatory effect of the endocannabinoid, anandamide, in the rat pulmonary artery.
Baranowska-Kuczko M; MacLean MR; Kozłowska H; Malinowska B
Pharmacol Res; 2012 Sep; 66(3):251-9. PubMed ID: 22627170
[TBL] [Abstract][Full Text] [Related]
3. A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery.
White R; Hiley CR
Br J Pharmacol; 1997 Dec; 122(8):1573-84. PubMed ID: 9422801
[TBL] [Abstract][Full Text] [Related]
4. Virodhamine relaxes the human pulmonary artery through the endothelial cannabinoid receptor and indirectly through a COX product.
Kozłowska H; Baranowska M; Schlicker E; Kozłowski M; Laudañski J; Malinowska B
Br J Pharmacol; 2008 Dec; 155(7):1034-42. PubMed ID: 18806815
[TBL] [Abstract][Full Text] [Related]
5. Anandamide-induced relaxation of sheep coronary arteries: the role of the vascular endothelium, arachidonic acid metabolites and potassium channels.
Grainger J; Boachie-Ansah G
Br J Pharmacol; 2001 Nov; 134(5):1003-12. PubMed ID: 11682448
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of endothelium-dependent relaxation evoked by anandamide in isolated human pulmonary arteries.
Baranowska-Kuczko M; Kozłowska H; Kozłowski M; Schlicker E; Kloza M; Surażyński A; Grzęda E; Malinowska B
Naunyn Schmiedebergs Arch Pharmacol; 2014 May; 387(5):477-86. PubMed ID: 24682422
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta.
Herradón E; Martín MI; López-Miranda V
Br J Pharmacol; 2007 Nov; 152(5):699-708. PubMed ID: 17704831
[TBL] [Abstract][Full Text] [Related]
8. Endothelial vasodilatory cannabinoid receptor in the human pulmonary artery: a future option in the therapy of pulmonary hypertension?
Hornig B
J Hypertens; 2007 Nov; 25(11):2202-3. PubMed ID: 17921811
[No Abstract] [Full Text] [Related]
9. Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery.
Ho WS; Hiley CR
Br J Pharmacol; 2003 Apr; 138(7):1320-32. PubMed ID: 12711633
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries.
White R; Ho WS; Bottrill FE; Ford WR; Hiley CR
Br J Pharmacol; 2001 Oct; 134(4):921-9. PubMed ID: 11606334
[TBL] [Abstract][Full Text] [Related]
11. Vascular pharmacology of a novel cannabinoid-like compound, 3-(5-dimethylcarbamoyl-pent-1-enyl)-N-(2-hydroxy-1-methyl-ethyl)benzamide (VSN16) in the rat.
Hoi PM; Visintin C; Okuyama M; Gardiner SM; Kaup SS; Bennett T; Baker D; Selwood DL; Hiley CR
Br J Pharmacol; 2007 Nov; 152(5):751-64. PubMed ID: 17891160
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.
Járai Z; Wagner JA; Varga K; Lake KD; Compton DR; Martin BR; Zimmer AM; Bonner TI; Buckley NE; Mezey E; Razdan RK; Zimmer A; Kunos G
Proc Natl Acad Sci U S A; 1999 Nov; 96(24):14136-41. PubMed ID: 10570211
[TBL] [Abstract][Full Text] [Related]
13. Vasorelaxant effects of oleamide in rat small mesenteric artery indicate action at a novel cannabinoid receptor.
Hoi PM; Hiley CR
Br J Pharmacol; 2006 Mar; 147(5):560-8. PubMed ID: 16415907
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid agonists induce relaxation in the bovine ophthalmic artery: evidences for CB1 receptors, nitric oxide and potassium channels.
Romano MR; Lograno MD
Br J Pharmacol; 2006 Apr; 147(8):917-25. PubMed ID: 16474412
[TBL] [Abstract][Full Text] [Related]
15. Role of Ca2+-dependent potassium channels in in vitro anandamide-mediated mesenteric vasorelaxation in rats with biliary cirrhosis.
Yang YY; Lin HC; Huang YT; Lee TY; Hou MC; Wang YW; Lee FY; Lee SD
Liver Int; 2007 Oct; 27(8):1045-55. PubMed ID: 17845532
[TBL] [Abstract][Full Text] [Related]
16. Vasorelaxant activities of the putative endocannabinoid virodhamine in rat isolated small mesenteric artery.
Ho WS; Hiley CR
J Pharm Pharmacol; 2004 Jul; 56(7):869-75. PubMed ID: 15233865
[TBL] [Abstract][Full Text] [Related]
17. The effects of Delta9-tetrahydrocannabinol in rat mesenteric vasculature, and its interactions with the endocannabinoid anandamide.
O'Sullivan SE; Kendall DA; Randall MD
Br J Pharmacol; 2005 Jun; 145(4):514-26. PubMed ID: 15821751
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the peroxisome proliferator-activated receptor (PPAR) alpha in vascular response of endocannabinoids in the bovine ophthalmic artery.
Romano MR; Lograno MD
Eur J Pharmacol; 2012 May; 683(1-3):197-203. PubMed ID: 22429572
[TBL] [Abstract][Full Text] [Related]
19. TRPV4 channel activation leads to endothelium-dependent relaxation mediated by nitric oxide and endothelium-derived hyperpolarizing factor in rat pulmonary artery.
Sukumaran SV; Singh TU; Parida S; Narasimha Reddy ChE; Thangamalai R; Kandasamy K; Singh V; Mishra SK
Pharmacol Res; 2013 Dec; 78():18-27. PubMed ID: 24075884
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of l-alpha-lysophosphatidylinositol-induced relaxation in human pulmonary arteries.
Karpińska O; Baranowska-Kuczko M; Malinowska B; Kloza M; Kusaczuk M; Gęgotek A; Golec P; Kasacka I; Kozłowska H
Life Sci; 2018 Jan; 192():38-45. PubMed ID: 29155298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
